Key points
-
Epilepsy is common in low-income and middle-income countries and aetiologies seem to differ from high-income countries
-
Neurocysticercosis and post-ischaemic lesions are common CT findings among people with epilepsy in eastern Africa
-
Many people with epilepsy are either not on anti-seizure medication or are underdosed resulting in high seizure frequency
-
Carbamazepine, Phenobarbital, and Phenytoin are commonly used anti-seizure medication whereas Valproic acid is only rarely used
-
Injuries due to epileptic seizures are common in eastern Africa and may reflect the high seizure-related mortality
Background
Methods
Evaluation of epilepsy
Statistical analysis
Results
Tanzania (Dar es Salaam) | Tanzania (Haydom) | Malawi | Uganda | Overall | Overall (with CT available) | ||
---|---|---|---|---|---|---|---|
Urban | Rural | Rural | Rural | ||||
Hospital-based | Hospital-based | Community-based | Community-based | ||||
n | 302 | 212 | 365 | 300 | 1179 | 941 | |
Epilepsy prevalence (95%CI) | 1.1% (1.0–1.3%) | 3.3% (3.1–3.4%) | |||||
Sex | female | 160 (53.0) | 104 (49.1) | 189 (51.8) | 128 (42.7) | 581 (49.3) | 460 (48.9) |
male | 142 (47.0) | 108 (50.9) | 176 (48.2) | 172 (57.3) | 598 (50.7) | 481 (51.1) | |
Age group | children (< 15 years) | 58 (19.2) | 42 (19.8) | 103 (29.3) | 57 (19.0) | 260 (22.3) | 203 (21.6) |
adolescents (15–29 years) | 148 (49.0) | 113 (53.3) | 141 (40.2) | 154 (51.3) | 556 (47.7) | 462 (49.1) | |
adults (30–49 years) | 73 (24.2) | 38 (17.9) | 77 (21.9) | 61 (20.3) | 249 (20.6) | 194 (20.6) | |
elderly (≥ 50 years) | 23 (7.6) | 19 (9.0) | 30 (8.5) | 28 (9.3) | 100 (8.6) | 82 (8.7) | |
Age in years | median (IQR) | 23 [16–32] | 22 [15–30] | 21 [13–32] | 21 [15–32] | 22 [15–32] | 22 [15–32] |
Marital status | single | 232 (76.8) | 126 (59.4) | 232 (63.6) | 58 (19.3) | 648 (54.9) | 226 (24) |
married/cohabiting | 54 (17.9) | 81 (38.2) | 92 (25.2) | 55 (18.3) | 282 (23.9) | 51 (5.4) | |
seperated/divorced/widowed | 14 (4.6) | 5 (2.4) | 38 (10.4) | 24 (8) | 82 (6.9) | 497 (52.8) | |
unknown | 2 (0.7) | 0 (0) | 3 (0.8) | 163 (54.3) | 168 (14.2) | 167 (17.7) | |
Religion | Christian | 151 (50) | 189 (89.2) | 215 (58.9) | 284 (94.7) | 839 (71.2) | 707 (75.1) |
Muslim | 148 (49) | 3 (1.4) | 147 (40.3) | 6 (2.0) | 304 (25.8) | 199 (21.1) | |
other | 0 (0.0) | 6 (2.8) | 3 (0.8) | 10 (3.3) | 19 (1.6) | 18 (1.9) | |
unknown | 3 (1.0) | 14 (6.6) | 0 (0.0) | 0 (0.0) | 17 (1.4) | 17 (1.8) | |
Occupation | farmer | 0 (0) | 196 (92.5) | 179 (49.0) | 91 (30.3) | 466 (39.5) | 334 (35.5) |
professional | 59 (19.5) | 0 (0) | 7 (1.9) | 3 (1) | 69 (5.9) | 66 (7.0) | |
student | 93 (30.8) | 0 (0) | 103 (28.2) | 0 (0) | 196 (16.6) | 149 (15.8) | |
trader/business | 3 (1) | 5 (2.4) | 15 (4.1) | 9 (3) | 32 (2.7) | 20 (2.1) | |
other | 15 (5) | 8 (3.8) | 27 (7.4) | 197 (65.7) | 247 (20.9) | 226 (24.0) | |
none | 123 (40.7) | 3 (1.4) | 14 (3.8) | 0 (0) | 140 (11.9) | 134 (14.2) | |
unknown | 9 (3) | 0 (0) | 20 (5.5) | 0 (0) | 29 (2.5) | 12 (1.3) | |
Pork consumption | 155 (51.7) | 162 (77.5) | 103 (29) | 213 (71.2) | 637 (54.0) | 568 (61.1) | |
Family pork consumption | 184 (61.3) | 87 (41.0) | NA | NA | 271 (52.9) | 271 (52.9) | |
Free roaming pigs living close by | 23 (7.7) | NA | 58 (16) | 86 (28.8) | 167 (14.2) | 134 (18.6) | |
Latrine use | 221 (90.6) | 203 (97.1) | NA | 220 (73.6) | 644 (85.6) | 644 (85.6) |
Characteristics and treatment of patients with epilepsy
Tanzania (Dar es Salaam) | Tanzania (Haydom) | Malawi | Uganda | ||
---|---|---|---|---|---|
n | 302 | 212 | 365 | 300 | |
Loss of consciousness | 300 (99.3) | 210 (99.1) | 359 (98.4) | 287 (95.7) | |
Motor activity | tonic–clonic | 211 (69.9) | 178 (84.0) | 311 (85.2) | 213 (71.0) |
tonic | 31 (10.3) | 25 (11.8) | 21 (5.7) | 58 (19.3) | |
clonic | 12 (4.0) | 9 (4.2) | 25 (6.8) | 15 (5.0) | |
myoclonic | 0 | 0 | 0 | 5 (1.7) | |
eye rolling/teeth grinding only | 19 (6.3) | 0 | 3 (0.8) | 9 (3.0) | |
no movements at all | 29 (9.6) | 0 | 5 (1.4) | 0 | |
Motor activity: side of body | bilateral | 239 (79.9) | 179 (84.4) | 249 (75.9) | 283 (94.3) |
unilateral | 31 (10.4) | 33 (15.6) | 74 (22.6) | 17 (5.7) | |
none | 29 (9.7) | 0 | 5 (1.5) | 0 | |
Information missing | 3 | 3 | 37 | 0 | |
Other signs observed (froth from the mouth, urine/stool incontinence) | 246 (81.5) | 199 (93.9) | 323 (88.5) | 287 (95.7) | |
Injuries during seizures | 56 (18.5) | 86 (40.6) | 204 (56.2) | 150 (50.0) | |
face/head | 22/46 (47.8) | 29/82 (35.4) | 83/177 (46.9) | 94/149 (63.1) | |
thorax | 1/46 (2.2) | 3/82 (3.7) | 49/177 (27.7) | 7/149 (4.7) | |
limbs | 16/46 (34.8) | 58/82 (70.7) | 45/177 (25.4) | 81/149 (54.4) | |
Information missing | 10 | 4 | 27 | 1 | |
Treatment for injuries | 34 (65.4) | NA | 56 (27.5) | 105 (70.5) | |
operation | 3/31 (9.7) | NA | 1/22 (4.5) | 3/105 (2.9) | |
stitching | 4/31 (12.9) | NA | 0/22 | 0/105 | |
dressing | 27/31 (87.1) | NA | 20/22 (90.9) | 81/105 (77.1) | |
medication | 4/31 (12.9) | NA | 15/22 (68.2) | 14/105 (13.3) | |
other | 1/31 (3.2) | NA | 0/22 | 7/105 (6.7) | |
information missing | 3 | NA | 34 | 0 | |
Reorientation after seizures | 285 (95.0) | 210 (99.5) | 335 (91.8) | 201 (67.0) | |
Age seizures started (years) | median (IQR) | 15 (11–22) | 15 (11–23) | 10 (6–20) | 14 (11–23) |
younger than 21 | 222 (74.0) | 152 (72.0) | 237 (77.5) | 218 (72.7) | |
older than 21 | 78 (26.0) | 59 (28.0) | 82 (22.5) | 82 (27.3) | |
Frequency of seizures | daily to weekly | 44 (14.9) | 0 | 57 (17.5) | 9 (4.1) |
weekly to monthly | 31 (10.5) | 4 (1.9) | 123 (37.7) | 18 (8.2) | |
monthly to yearly | 158 (53.6) | 44 (21.0) | 131 (40.2) | 145 (66.2) | |
yearly or less often | 62 (21.0) | 162 (77.1) | 15 (4.6) | 47 (21.5) | |
Time since last seizure | < 1 month | 169 (56.5) | 62 (29.5) | NA | 10 (3.4) |
1–3 months | 82 (27.4) | 41 (19.5) | NA | 5 (1.7) | |
3–12 months | 42 (14.0) | 36 (17.1) | NA | 20 (6.8) | |
1–2 years | 3 (1.0) | 27 (12.9) | NA | 69 (23.6) | |
> 2 years | 3 (1.0) | 44 (21.0) | NA | 188 (64.4) | |
Occurence of seizures | anytime | 208 (69.3) | 42 (24.6) | 115 (31.8) | 163 (54.3) |
daytime | 54 (18.0) | 25 (14.6) | 119 (32.9) | 77 (25.7) | |
evening/night | 6 (2.0) | 47 (27.5) | 32 (8.8) | 40 (13.3) | |
night while asleep | 32 (10.7) | 57 (33.3) | 96 (26.5) | 20 (6.7) | |
Precipitants before seizures | 90 (30.2) | 114 (53.8) | 31 (8.5) | 88 (29.3) | |
alcohol | 0/89 | 15/114 (13.2) | 5/31 (16.1) | 0/88 | |
fever | 13/89 (14.6) | 30/114 (26.3) | 16/31 (51.6) | 28/88 (31.8) | |
stress/emotional stimuli | 14/89 (15.7) | 18/114 (15.8) | 2/31 (6.5) | 32/88 (36.4) | |
lack of sleep | 59/89 (66.3) | 0/114 | 2/31 (6.5) | 5/88 (5.7) | |
other | 9/89 (10.1) | 62/114 (54.4) | 6/31 (19.4) | 23/88 (26.1) | |
missing | 1 | 0 | 0 | 0 | |
History of febrile seizures | 106 (35.7) | 16 (7.6) | 177 (48.4) | 47 (15.7) | |
Past medical history | 7 (2.3) | NA | 37 (10.1) | 33 (11.1) | |
metabolic/cardiovascular | 3/7 (42.9) | NA | 3/37 (8.1) | 2/33 (6.1) | |
respiratory | 1/7 (14.3) | NA | 10/37 (27.0) | 4/33 (12.1) | |
infectious | 3/7 (42.9) | NA | 19/37 (51.4) | 23/33 (69.7) | |
other | 0/7 | NA | 5/37 (13.5) | 4/33 (12.1) | |
missing | 0 | NA | 0 | 0 | |
Hospital admission | 97 (32.4) | 145 (68.4) | 139 (38.1) | 118 (39.3) | |
Past psychiatric history | 162 (53.6) | 18 (8.5) | 62 (17.0) | 20 (6.7) | |
Type | psychosis | 72/162 (44.4) | 0/18 | 17/62 (27.4) | 6/20 (30.0) |
depression | 13/162 (8.0) | 0/18 | 2/62 (3.2) | 7/20 (35.0) | |
behavioural problems | 19/162 (11.7) | 4/18 (22.2) | 22/62 (35.5) | 3/20 (15.0) | |
dementia | 49/162 (30.2) | 0/18 | 1/62 (1.6) | 2/20 (10.0) | |
mental retardation | 33/162 (20.4) | 16/18 (88.9) | 29/62 (46.8) | 14/20 (70.0) | |
missing | 0 | 0 | 0 | 0 | |
Family history of epilepsy | 101 (34.1) | 57 (26.9) | 107 (29.3) | 88 (29.3) | |
Degree family member | first degree | 47/100 (47.0) | 39/57 (68.4) | 43/101 (42.6) | 11/86 (12.8) |
second degree | 53/100 (53.0) | 18/57 (31.6) | 58/101 (57.4) | 75/86 (87.2) | |
missing | 1 | 0 | 6 | 2 | |
Mother not healthy during pregnancy | 31 (12.0) | 5 (2.4) | 15 (4.1) | 9 (3.0) | |
Schooling | 275 (91.7) | 143 (67.5) | 273 (74.8) | 192 (64.0) | |
Drop-out of school | 55 (20.1) | 59 (27.8) | 162 (44.4) | 118 (61.5) | |
Focal neurological signs on examination | 23 (7.8) | NA | 31 (8.5) | 0 | |
Diagnosis ILAE | generalised onset | 240 (79.5) | 149 (70.3) | 288 (78.9) | 277 (92.3) |
focal onset | 61 (20.2) | 61 (28.8) | 77 (21.1) | 23 (7.7) | |
unclassified | 1 (0.3) | 2 (0.9) | 0 | 0 | |
Diagnosis Winkler et al.21 | gen. seizures within a specific age range | 175 (57.9) | 119 (56.1) | 109 (29.9) | 127 (42.3) |
gen. seizures outside specific age range | 47 (15.6) | 30 (14.2) | 152 (41.6) | 67 (22.3) | |
gen. seizures with diffuse brain damage | 18 (6.0) | 14 (6.6) | 47 (12.9) | 83 (27.7) | |
gen. seizures with focal signs | 57 (18.9) | 47 (22.2) | 45 (12.3) | 23 (7.7) | |
simple partial seizures | 2 (0.7) | 0 | 8 (2.2) | 0 | |
complex partial seizures | 2 (0.7) | 0 | 4 (1.1) | 0 | |
unclassified | 1 (0.3) | 2 (0.9) | 0 | 0 |
Overall (n = 941); n (%)a | Focal onset seizures (n = 168); n (%) | Generalised onset seizures (n = 771); n (%) | Unclassified seizures (n = 2); n (%) | |
---|---|---|---|---|
Atrophy | 77 (8.2) | 10 (6.0) | 67 (8.7) | 0 (0) |
Hydrocephalus | 7 (0.7) | 2 (1.2) | 5 (0.6) | 0 (0) |
Post-ischaemic lesion | 74 (7.9) | 18 (10.7) | 56 (7.3) | 0 (0) |
Post-haemorrhagic lesion | 4 (0.4) | 0 (0) | 4 (0.5) | 0 (0) |
Traumatic lesion | 3 (0.3) | 3 (1.8) | 0 (0) | 0 (0) |
Tumorous lesion | 7 (0.7) | 3 (1.8) | 4 (0.5) | 0 (0) |
NCC | 70 (7.4) | 16 (9.5) | 54 (7) | 0 (0) |
Other | 55 (5.8) | 19 (11.3) | 36 (4.7) | 0 (0) |
Unremarkable | 728 (77.4) | 109 (64.9) | 617 (80) | 2 (100) |
Tanzania (Dar es Salaam) | Tanzania (Haydom) | Malawi | Uganda | ||
---|---|---|---|---|---|
N | 302 | 212 | 365 | 300 | |
ASM | 270 (89.7) | 209 (98.6) | 248 (67.9) | 233 (77.7) | |
ASM type | monotherapy | 243/268 (90.7) | 209/209 (100) | 222/229 (96.9) | 233/233 (100) |
carbamazepine | 134/268 (50.0) | 156/209 (74.6) | 7/229 (3.1) | 31/233 (13.3) | |
phenobarbital | 103/268 (38.4) | 53/209 (25.4) | 201/229 (87.8) | 55/233 (23.6) | |
phenytoin | 2/268 (0.7) | 0/209 | 14/229 (6.1) | 147/233 (63.1) | |
valproic acid | 4/268 (1.5) | 0/209 | 0/229 | 0/233 | |
combination therapy | 25/268 (9.3) | 0/209 | 7/229 (3.1) | 0/233 | |
carbamazepine, phenobarbital | 13/268 (4.9) | 0/209 | 0/229 | 0/233 | |
carbamazepine, phenytoin | 4/268 (1.5) | 0/209 | 2/229 (0.9) | 0/233 | |
carbamazepine, valproic acid | 1/268 (0.4) | 0/209 | 0/229 | 0/233 | |
phenobarbital, gabapentin | 1/268 (0.4) | 0/209 | 0/229 | 0/233 | |
phenobarbital, phenytoin | 6/268 (2.2) | 0/209 | 5/229 (2.2) | 0/233 | |
missing/unknown | 2 | 0 | 19 | 0 | |
Ever treated with other ASM | 78 (27.2) | NA | NA | 31 (10.3) | |
Reason for changing ASM | no response | 9/24 (37.5) | NA | NA | 17/31 (54.8) |
side effects | 8/24 (33.3) | NA | NA | 0/31 | |
stock-out | 2/24 (8.3) | NA | NA | 5/31 (16.1) | |
other | 5/24 (20.8) | NA | NA | 9/31 (29.0) | |
missing | 54 | NA | NA | 0 | |
Herbal treatment | 159 (53.5) | 105 (49.5) | 304 (83.2) | 108 (36.0) | |
Scarification | 56 (19.2) | 43 (20.3) | 33 (9.0) | 10 (3.3) |